12:30-1:30pm, Thursday 26 November 2015
Seminar Room 410, Level 4, 207 Bouverie Street, Carlton
Mr Jesse Young, Research Fellow and PhD candidate, Centre for Mental Health
In 2005, following an increase in consumer co-payments for medicines subsidised on the Pharmaceutical Benefits Scheme (PBS), many medicines decreased in use. However use of atypical antipsychotics did not.
We aimed to determine whether the 21% PBS co-payment increase in 2005 affected utilisation of atypical antipsychotics restricted for schizophrenia and bipolar disorder in Western Australia. This presentation will discuss the evidence of interrupted utilisation of these medicines, how a subset of the study population were particularly affected, along with clinical and policy implications.
For more details, please view the Event Flyer.
All other enquiries to Nicky Woods, Tel: 03 8344 0908.